BRIEF-Cipher Pharmaceuticals Q2 loss per share c$0.13
Aug 10 (Reuters) - Cipher Pharmaceuticals Inc
* Cipher pharmaceuticals reports q2 2016 results highlighted by 32% revenue growth and $3.1 million cash from operations
* Cipher pharmaceuticals inc qtrly total revenue of $11.7 million, an increase of 32% from $8.8 million in q2 2015
* Q2 loss per share c$0.13 Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.